Cart
Free US shipping over $10
Proud to be B-Corp

Treat to Target in Rheumatic Diseases: Rationale and Results Summary

Treat to Target in Rheumatic Diseases: Rationale and Results: Volume 45-4 by Daniel Aletaha (Division of Rheumatology, Department of Internal Medicine 3, Medical University Vienna, Austria)

Guest edited by Dr. Daniel Aletaha, this issue of Rheumatic Disease Clinics will cover Treat to Target in Rheumatic Diseases with a focus on rationale and results. This issue is one of four selected each year by our series Consulting Editor, Dr. Michael Weisman. Articles explore diseases, including, but not limited to: History, Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthropathies, Systemic lupus erythematosus, PMR and GCA, Inflammatory Myopathies (PM/DM), Gout, and Subclinical Targets.

About Daniel Aletaha (Division of Rheumatology, Department of Internal Medicine 3, Medical University Vienna, Austria)

Daniel Aletaha is a consultant rheumatologist at the Medical University of Vienna and a renowned scientist in outcomes research, clinical trials, and translational research in rheumatoid arthritis and other inflammatory rheumatic diseases. He received academic degrees from the Medical University in Vienna, Duke University in North Carolina, and Danube University Krems. Daniel has spent more than two years at the National Institutes of Health in Bethesda, Maryland. Daniel Aletaha is a highly cited author of the field of rheumatology and author of more than 200 publications. He is also associate editor of Arthritis and Rheumatology and RMD Open, and editorial board member of a number of rheumatology specialty journals.

Additional information

NGR9780323678964
9780323678964
0323678963
Treat to Target in Rheumatic Diseases: Rationale and Results: Volume 45-4 by Daniel Aletaha (Division of Rheumatology, Department of Internal Medicine 3, Medical University Vienna, Austria)
New
Hardback
Elsevier - Health Sciences Division
2019-09-30
N/A
Book picture is for illustrative purposes only, actual binding, cover or edition may vary.
This is a new book - be the first to read this copy. With untouched pages and a perfect binding, your brand new copy is ready to be opened for the first time

Customer Reviews - Treat to Target in Rheumatic Diseases: Rationale and Results